Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial

• Main Authors: Dimopoulos, Meletios A, Spicka, Ivan, Quach, Hang, Oriol, Albert, Hajek, Roman, Garg, Mamta, Beksac, Meral, Bringhen, Sara, Katodritou, Eirini, Chng, Wee-Joo, Leleu, Xavier, Iida, Shinsuke, Mateos, Maria-Victoria, Morgan, Gareth, Vorog, Alexander, Labotka, Richard, Wang, Bingxia, Palumbo, Antonio, Lonial, Sagar
• Other Authors: DEAN'S OFFICE (MEDICINE)
• Format: Article
• Language: English
• Published: AMER SOC CLINICAL ONCOLOGY 2022
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; CONTINUOUS THERAPY; PLUS LENALIDOMIDE; FIXED DURATION; DOUBLE-BLIND; OPEN-LABEL; BORTEZOMIB; DEXAMETHASONE; OUTCOMES; DARATUMUMAB; PREDNISONE
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/229088
• Institution: National University of Singapore

10.1200/JCO.20.02060